Autolus Therapeutics plc is an early commercial-stage biopharmaceutical company developing next-generation T cell therapies for cancer and autoimmune diseases. Its FDA-approved product AUCATZYL (obecabtagene autoleucel, obe-cel) treats adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). The company also has clinical programs in pediatric B-ALL, B-NHL, systemic lupus erythematosus, lupus nephritis, and multiple sclerosis, using proprietary CAR T cell programming technologies manufactured at its Nucleus facility in Stevenage, U.K.
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001730463-26-000038 | EDGAR | 145K words |
| 2025-03-20 | 2024-12-31 | 0001730463-25-000019 | EDGAR | 139K words |
| 2024-03-21 | 2023-12-31 | 0001730463-24-000048 | EDGAR | 141K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001730463-26-000123 | EDGAR | 27K words |
| 2025-11-12 | 2025-09-30 | 0001730463-25-000088 | EDGAR | 33K words |
| 2025-08-12 | 2025-06-30 | 0001730463-25-000067 | EDGAR | 32K words |
| 2025-05-08 | 2025-03-31 | 0001730463-25-000039 | EDGAR | 29K words |
| 2024-11-12 | 2024-09-30 | 0001730463-24-000136 | EDGAR | 74K words |
| 2024-08-08 | 2024-06-30 | 0001730463-24-000093 | EDGAR | 28K words |
| 2024-05-17 | 2024-03-31 | 0001730463-24-000064 | EDGAR | 26K words |
| 2023-11-09 | 2023-09-30 | 0001730463-23-000110 | EDGAR | 27K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001730463-26-000119 | EDGAR | 4K words |
| 2026-08-03 | 0001730463-26-000112 | EDGAR | 1K words |
| 2026-08-03 | 0001193125-26-329526 | EDGAR | 77K words |
| 2026-03-27 | 0001730463-26-000032 | EDGAR | 1K words |
| 2026-01-26 | 0001730463-26-000019 | EDGAR | 1K words |
| 2026-01-12 | 0001730463-26-000012 | EDGAR | 5K words |
| 2025-12-02 | 0001730463-25-000095 | EDGAR | 1K words |
| 2025-11-12 | 0001730463-25-000081 | EDGAR | 5K words |
| 2025-08-12 | 0001730463-25-000064 | EDGAR | 4K words |
| 2025-06-27 | 0001730463-25-000046 | EDGAR | 1K words |
120 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001730463 |
| Ticker | AUTL |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | X0 |
| Headquarters | Stevenage, United Kingdom |
| Website | https://www.autolus.com |
| Listed | 2018-06-22 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AUTL (~200 tokens, structured JSON with cryptographic provenance)